Articles related to Cardiology, Interventional

In this update to its 2014 recommendation, the USPSTF concluded “with moderate certainty that the harms of beta carotene supplementation outweigh the benefits for the prevention of cardiovascular disease or cancer.”

In a look “Beyond the Guidelines,” a preventive cardiologist and a general internist discuss their approach in the case of a 57-year-old woman with high cholesterol and a family history of heart disease.

In a 7-year study of 171,000 individuals with a mean age of 56 years, these researchers elucidate the hazard ratio for death from CVD or cancer and levels of daily coffee consumption.

A report in MedPage Today states that standard heart care is recommended for COVID-19 survivors left with cardiomyopathy and other cardiac conditions, though more answers are needed regarding how long they need to undergo special monitoring, and which groups are at particularly high risk.

There haven’t been any national guidelines developed for managing patients with stage 1 hypertension who don’t respond to lifestyle modification. This population represents an important guideline gap: most patients with stage 1 hypertension progress to stage 2 hypertension, which increases the risk for cardiovascular events. The AHA has published a scientific statement to fill the gap – if lifestyle modification fails to reduce blood pressure, consider pharmacotherapy.

The lipid metabolism plays an important role in the development of cardiovascular diseases and type 2 diabetes. However, little has been known about the molecular relationships. But now, a set of lipids have been statistically associated with cardiovascular disease and type 2 diabetes.